Buchanan Ingersoll & Rooney Helps Grignard Pure Obtain Additional EPA Approval for Its Antimicrobial Air Treatment Solution for Use in Four New States to Fight Covid-19

WASHINGTON, D.C. – July 9, 2021 – Buchanan Ingersoll & Rooney assisted Grignard Pure, an industry leader in providing specialty chemistry solutions, in obtaining U.S. Environmental Protection Agency (EPA) approval for the use of its antimicrobial air treatment solution designed to significantly reduce the viral load of the SARS-CoV-2 virus in the air for use in Maryland, Nevada, Pennsylvania, and Texas. This emergency exception enables the states to use Grignard Pure’s unregistered supplemental air treatment product in certain approved locations.

Earlier this year, the EPA issued emergency exemptions to Georgia and Tennessee permitting them to use Grignard Pure in health care facilities, intrastate transportation, food processing facilities, and indoor spaces within buildings – including government facilities – where people are conducting activity deemed essential by the state.

The EPA undertook a thorough review of the product’s health, safety and efficacy performance and determined that Grignard Pure is expected to kill more than 98 percent of the virus that causes COVID-19.

Buchanan’s Federal Government Relations team of Michael Strazzella, practice group leader, Edward Hild and Timothy Costa, principals, represented Grignard Pure in this matter.